Sonoma Pharmaceuticals Shares Soar 44% After Introducing New Product

Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of the most notable news stories of the time.

Getty Images

Shares of Sonoma Pharmaceuticals (SNOA) skyrocketed 44% on Friday after the healthcare company introduced in the European Union (EU) a new application for intraoperative pulse lavage irrigation treatment that could take the place of traditional IV bags for a range of surgical procedures.

Sonoma said that it developed this new application to cover an unmet need for a "non-toxic, irrigation solution that can prevent infection and improve healing time" for wounds.

It noted that the intraoperative pulse lavage container is designed to work with a "flush gun" for abdominal, laparoscopic, orthopedic, and periprosthetic operations.

The company said the product was produced "in close collaboration with the medical community and Sonoma's existing distribution partners in Europe." CEO Amy Trombly added the firm continues to see "increased demand for our wound care products in Europe."

Sonoma indicated it was already accepting orders for the pulse lavage irrigation treatment solution, which is expected to be ready for commercial use in Europe in September. It anticipates launch in the U.S. next year.

Friday's gains helped lift Sonoma Pharmaceuticals shares into positive territory for the year.

YCharts

Sonoma Pharmaceuticals. "Sonoma Pharmaceuticals Introduces Next Generation Solution for Pulse Lavage Irrigation in the European Union."